{
    "2021-01-25": [
        [
            {
                "time": "",
                "original_text": "医药生物行业周报：2020Q4公募基金重仓医药持仓几何？继续强调Q1医药躁动期",
                "features": {
                    "keywords": [
                        "医药生物",
                        "公募基金",
                        "重仓",
                        "Q4",
                        "Q1",
                        "躁动期"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "去年四季度TPO50主动权益类基金，前十大重仓股平均换股3.7只",
                "features": {
                    "keywords": [
                        "去年四季度",
                        "TPO50",
                        "主动权益类基金",
                        "重仓股",
                        "换股"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}